The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kevin Spencer

Prenatal Screening Unit

Department of Clinical Biochemistry

King George Hospital

Barley Lane

UK

[email]@aol.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Prenatal Screening Unit, Department of Clinical Biochemistry, King George Hospital, Barley Lane, UK. 2002 - 2011

References

  1. First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection. Spencer, K. Fetal. Diagn. Ther. (2011) [Pubmed]
  2. Early vaginal bleeding has no impact on markers used in first trimester aneuploidy screening. Spencer, K., Spencer, C.E., Stamatopoulou, A., Staboulidou, I., Nicolaides, K.H. Prenat. Diagn. (2010) [Pubmed]
  3. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Spencer, K., Cowans, N.J., Spencer, C.E., Achillea, N. Prenat. Diagn. (2010) [Pubmed]
  4. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Spencer, K., Staboulidou, I., Nicolaides, K.H. Prenat. Diagn. (2010) [Pubmed]
  5. Is maternal renal disease a cause of elevated free beta-hCG in first trimester aneuploidy screening? Spencer, K., Enofe, O., Cowans, N.J., Stamatopoulou, A. Prenat. Diagn. (2009) [Pubmed]
  6. Maternal serum screening marker levels in women with a previous aneuploidy pregnancy. Spencer, K., Staboulidou, I., De Jesus Cruz, J., Karagiannis, G., Nicolaides, K.H. Prenat. Diagn. (2009) [Pubmed]
  7. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Spencer, K., Cowans, N.J., Avgidou, K., Molina, F., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2008) [Pubmed]
  8. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Spencer, K., Kagan, K.O., Nicolaides, K.H. Prenat. Diagn. (2008) [Pubmed]
  9. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Spencer, K., Cowans, N.J., Stamatopoulou, A. Prenat. Diagn. (2008) [Pubmed]
  10. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Spencer, K., Cowans, N.J., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2008) [Pubmed]
  11. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Spencer, K., Cowans, N.J., Molina, F., Kagan, K.O., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2008) [Pubmed]
  12. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Spencer, K., Cowans, N.J., Nicolaides, K.H. Prenat. Diagn. (2008) [Pubmed]
  13. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation. Spencer, K., Vereecken, A., Cowans, N.J. Prenat. Diagn. (2008) [Pubmed]
  14. First-trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?. Spencer, K., Cowans, N.J., Uldbjerg, N., Tørring, N. Prenat. Diagn. (2008) [Pubmed]
  15. Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21. Spencer, K., Cowans, N.J., Stamatopoulou, A. Prenat. Diagn. (2008) [Pubmed]
  16. First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?. Spencer, K., Cowans, N.J., Uldbjerg, N., Vereecken, A., Tørring, N. Prenat. Diagn. (2008) [Pubmed]
  17. Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy. Spencer, K., Cowans, N.J., Stamatopoulou, A. Prenat. Diagn. (2007) [Pubmed]
  18. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. Spencer, K., Cowans, N.J. J. Matern. Fetal. Neonatal. Med. (2007) [Pubmed]
  19. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia. Spencer, K., Cowans, N.J., Chefetz, I., Tal, J., Kuhnreich, I., Meiri, H. Prenat. Diagn. (2007) [Pubmed]
  20. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Spencer, K., Cowans, N.J., Chefetz, I., Tal, J., Meiri, H. Ultrasound. Obstet. Gynecol (2007) [Pubmed]
  21. Aneuploidy screening in the first trimester. Spencer, K. American J. Medical Genetics. C, Seminars Medical Genetics (2007) [Pubmed]
  22. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Spencer, K., Yu, C.K., Savvidou, M., Papageorghiou, A.T., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2006) [Pubmed]
  23. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer, K., Cowans, N.J., Avgidou, K., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2006) [Pubmed]
  24. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Spencer, K. Ann. Clin. Biochem. (2005) [Pubmed]
  25. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13. Spencer, K., Crossley, J.A., Aitken, D.A., Nicolaides, K.H. Prenat. Diagn. (2005) [Pubmed]
  26. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Spencer, K., Heath, V., El-Sheikhah, A., Ong, C.Y., Nicolaides, K.H. Prenat. Diagn. (2005) [Pubmed]
  27. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Spencer, K., Yu, C.K., Cowans, N.J., Otigbah, C., Nicolaides, K.H. Prenat. Diagn. (2005) [Pubmed]
  28. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Spencer, K., Cicero, S., Atzei, A., Otigbah, C., Nicolaides, K.H. Prenat. Diagn. (2005) [Pubmed]
  29. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Spencer, K., Bindra, R., Cacho, A.M., Nicolaides, K.H. Prenat. Diagn. (2004) [Pubmed]
  30. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies. Spencer, K., Aitken, D. Ultrasound. Obstet. Gynecol (2004) [Pubmed]
  31. The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system. Spencer, K. Ann. Clin. Biochem. (2003) [Pubmed]
  32. Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. Spencer, K., de Kok, J.B., Swinkels, D.W. Prenat. Diagn. (2003) [Pubmed]
  33. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?. Spencer, K., Bindra, R., Nix, A.B., Heath, V., Nicolaides, K.H. Ultrasound. Obstet. Gynecol (2003) [Pubmed]
  34. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Spencer, K., Bindra, R., Nicolaides, K.H. Prenat. Diagn. (2003) [Pubmed]
  35. Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisited. Spencer, K. Prenat. Diagn. (2002) [Pubmed]
  36. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Spencer, K., Nicolaides, K.H. Prenat. Diagn. (2002) [Pubmed]
  37. Screening for chromosomal anomalies in the first trimester: does repeat maternal serum screening improve detection rates?. Spencer, K., Cuckle, H.S. Prenat. Diagn. (2002) [Pubmed]
  38. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy. Spencer, K. Prenat. Diagn. (2002) [Pubmed]
  39. Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy. Spencer, K., Crossley, J.A., Aitken, D.A., Nix, A.B., Dunstan, F.D., Williams, K. Ann. Clin. Biochem. (2002) [Pubmed]
 
WikiGenes - Universities